SFPIA
RDHL

Stevens First Principles Investment Advisors’s Redhill Biopharma RDHL Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1
Closed -$9K – 227
2015
Q2 		$9K Buy
+1
New +$15.9K 0.01% 199

Other funds holding RDHL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FM
Family Management New York $834M AUM 20.83% 1-Year Est. Return

Stevens First Principles Investment Advisors's RDHL Position: Q3 2015 in Review

Stevens First Principles Investment Advisors sold out of Redhill Biopharma (RDHL) in Q3 2015, closing a stake of 1 share — an estimated $9K sold.

Stevens First Principles Investment Advisors first reported a position in RDHL in Q2 2015 and held it in 1 quarter. The position peaked at $9K in Q2 2015. 22 funds tracked by Wall St. Rank hold RDHL as of Q3 2015.

  • Stevens First Principles Investment Advisors reported no remaining Redhill Biopharma position as of Q3 2015 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 1 Redhill Biopharma share in Q3 2015, an estimated $9K.
  • Stevens First Principles Investment Advisors first reported a position in Redhill Biopharma in Q2 2015 and held it in 1 quarter.
  • Stevens First Principles Investment Advisors's Redhill Biopharma position peaked at $9K in Q2 2015.
  • 22 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.